Mon, Nov 16, 2026 - Page 45
8174 indexed SquawkNews stories from this UTC day. Showing 5281-5400.
L
POET Technologies Inc. (POET) Q3 Revenue Rose 244% to $1.03M
POET reported Q3 2026 revenue of $1.03M, up 244% year over year and 80% sequentially. Net loss narrowed to $7.6M from $9.4M a year earlier; quarter-end cash and short-term investments were $774.3M.Material DetailsContext
EARNINGS | Nov 16, 2026, 12:07 PM UTC
L
Duke Robotics Names Avi Levin Chief Financial Officer
EQUITY | Nov 16, 2026, 12:07 PM UTC
M
GXO Sees 2027 Organic Revenue Growth Above 5.5%
EARNINGS | Nov 16, 2026, 12:07 PM UTC
L
POET Technologies Reports Record Q3 2026 Revenue of $1.03M, Up 244%
Seventh consecutive quarter of sequential growth; loss per share improves to $(0.04) from $(0.07); $774.3 million in cash and short-term investmentsTORONTO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. NASDAQ
EARNINGS | Nov 16, 2026, 12:07 PM UTC
M
Prelude Therapeutics Reports Q3 Net Loss of $12.5 Million
Prelude reported a Q3 net loss of $12.5 million, or $0.12 per share, compared with $19.7 million, or $0.26 per share, a year earlier. It had $142.7 million in cash, equivalents, restricted cash and marketable securities
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Invivyd, Inc. (IVVD) Reports Q3 2026 Results; VYD2311 Data Update Expected Imminently
Invivyd reported third-quarter 2026 results and business updates. The company said VYD2311 DECLARATION data and a regulatory update are expected imminently; the release text provided contains no financial figures.Materia
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Unicycive Therapeutics, Inc. (UNCY) Reports $7.0M Q3 Net Loss; Cash Runway Beyond 2027
Unicycive reported a Q3 2026 net loss of $7.0M, or $0.25 per share, versus $6.0M, or $0.33 per share, in Q3 2025. Cash, cash equivalents and marketable securities were approximately $59M at September 30, with expected ru
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Volkswagen Canada Marks Five Years of Game Changers
Volkswagen Canada recognized five new Game Changers for contributions to local soccer communities.
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Domino's Launches New Sweet Heat Smokehouse Pizza
EQUITY | Nov 16, 2026, 12:07 PM UTC
M
Brazil's IBC-Br falls 0.2% in September
Central bank data showed economic activity contracted 0.2% month over month, versus economists' forecast for a 0.29% decline.
MACRO | Nov 16, 2026, 12:07 PM UTC
L
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights
NEW HAVEN, Conn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. NASDAQ:IVVD today announced financial results for the third quarter ended September 30, 2026, and recent business highlights.“We are excited about the pro
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Enrollment of Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR+ breast cancer is underway; initial proof of concept data anticipated in the 2nd half of 2027Entered into a clinical tr
EQUITY | Nov 16, 2026, 12:07 PM UTC
L
Unicycive Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
MOUNTAIN VIEW, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) NASDAQ:UNCY, a biotechnology company developing therapies for patients with kidney disease, today annou
EQUITY | Nov 16, 2026, 12:06 PM UTC
L
Matternet Names Ben Dobson CFO
Matternet appointed Ben Dobson, formerly Joby’s finance head, as chief financial officer.
EQUITY | Nov 16, 2026, 12:06 PM UTC
M
Bitcoin Falls Below $65,000 as CZ Cites Possible Factors
Bitcoin lost support at $65,000. Binance co-founder Changpeng Zhao cited possible explanations including capital shifting toward Anthropic’s upcoming IPO, institutional withdrawals and security concerns, while cautioning
CRYPTO | Nov 16, 2026, 12:06 PM UTC
L
Xtant Medical swings to Q3 net loss of $3.56 million from year-earlier profit; Q3 revenue falls 27% year over year to $24.29 million
Xtant Medical swings to Q3 net loss of $3.56 million from year-earlier profit; Q3 revenue falls 27%
EARNINGS | Nov 16, 2026, 12:06 PM UTC
H
XTANT MEDICAL HOLDINGS INC: NOT PROVIDING REVISED FULL-YEAR 2026 FINANCIAL GUIDANCE
XTANT MEDICAL HOLDINGS INC: NOT PROVIDING REVISED FULL-YEAR 2026 FINANCIAL GUIDANCE
EARNINGS | Nov 16, 2026, 12:06 PM UTC
L
Prelude Therapeutics: Cash Runway Into 2Q 2028 >PRLD
Prelude Therapeutics: Cash Runway Into 2Q 2028 >PRLD
EQUITY | Nov 16, 2026, 12:06 PM UTC
H
XTANT MEDICAL - NO LONGER EXPECTS TO ACHIEVE PREVIOUSLY ISSUED FULL-YEAR 2026 GUIDANCE
XTANT MEDICAL - NO LONGER EXPECTS TO ACHIEVE PREVIOUSLY ISSUED FULL-YEAR 2026 GUIDANCE
EARNINGS | Nov 16, 2026, 12:05 PM UTC
L
POET Technologies 3Q Loss/Shr 4c >POET
POET Technologies 3Q Loss/Shr 4c >POET
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Prelude Therapeutics 3Q Rev $5.65M >PRLD
Prelude Therapeutics 3Q Rev $5.65M >PRLD
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Unicycive Therapeutics 3Q Loss/Shr 25c >UNCY
Unicycive Therapeutics 3Q Loss/Shr 25c >UNCY
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Unicycive Therapeutics 3Q Loss $7M >UNCY
Unicycive Therapeutics 3Q Loss $7M >UNCY
EQUITY | Nov 16, 2026, 12:05 PM UTC
H
Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the final session of last week, while S&P 500 futures slipped 0.3%.
Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the
EARNINGS | Nov 16, 2026, 12:05 PM UTC
M
Belrise Industries shares surge 13% after Q2 results
Belrise Industries shares rose 13% on Monday after the company reported Q2 FY27 results. The headline also cites an H-One merger and a 44% one-year stock rally.
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Aker BP Completes LTIP Share Awards and Issues New Grants
Aker BP finalised share awards under its 2023–2026 Long-Term Incentive Programme.
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
POET Technologies 3Q Rev $1.0M >POET
POET Technologies 3Q Rev $1.0M >POET
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Invivyd 3Q Loss/Shr 10c Vs. Loss 6c >IVVD
Invivyd 3Q Loss/Shr 10c Vs. Loss 6c >IVVD
EQUITY | Nov 16, 2026, 12:05 PM UTC
L
Instil Bio 3Q Loss/Shr 62c >TIL
Instil Bio 3Q Loss/Shr 62c >TIL
EQUITY | Nov 16, 2026, 12:05 PM UTC
H
Tech Slides & Nvidia Tests Loom - Europe Market Wrap
Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the
CRYPTO | Nov 16, 2026, 12:05 PM UTC
L
Instil Bio 3Q Loss $4.23M >TIL
Instil Bio 3Q Loss $4.23M >TIL
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
GT Biopharma 3Q Loss $3.5M >GTBP
GT Biopharma 3Q Loss $3.5M >GTBP
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Buffett to Convert 6,150 Berkshire Class A Shares Into 9,225,000 Class B Shares
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
JPMorgan Credit Card Delinquency Rate at 0.84% in October
JPMorgan reported a credit card delinquency rate of 0.84% at the end of October.
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Invivyd 3Q Rev $15.4M >IVVD
Invivyd 3Q Rev $15.4M >IVVD
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Buffett to Convert 6,150 Berkshire Class A Shares Into 9,225,000 Class B Shares
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Deutsche Bank cuts Flowers Foods price target to $6 from $8
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Invivyd Appoints Marc W. Elia as CEO
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
AirJoule Technologies 3Q Loss/Shr 27c >AIRJ
AirJoule Technologies 3Q Loss/Shr 27c >AIRJ
EQUITY | Nov 16, 2026, 12:04 PM UTC
L
Diamondback boosts Permian presence with $5.03 billion deal for some Double Eagle units
Diamondback Energy NASDAQ:FANG said on Monday it would buy certain units of Double Eagle in the Permian Basin for $5.03 billion in cash and stock, deepening its presence in the oil-rich region.The deal extends the US sha
ENERGY | Nov 16, 2026, 12:04 PM UTC
L
CYPHERPUNK TECHNOLOGIES Q3 MINING REVENUE $9.9 MILLION
CYPHERPUNK TECHNOLOGIES Q3 MINING REVENUE $9.9 MILLION
EARNINGS | Nov 16, 2026, 12:04 PM UTC
M
Diamondback Agrees to $5.03 Billion Deal for Double Eagle Units
Diamondback agreed to a $5.03 billion deal for some Double Eagle units, expanding its presence in the Permian.
MNA | Nov 16, 2026, 12:04 PM UTC
L
Berkshire Hathaway: Warren E. Buffett, Chairman Emeritus, Will Convert 6,150 Class A Shares Into 9,225,000 Class B Shares
Berkshire Hathaway: Warren E. Buffett, Chairman Emeritus, Will Convert 6,150 Class A Shares Into 9,225,000 Class B Shares
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
JPMorgan Reports October Credit Card Charge-Off Rate of 1.44%
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
Vycor Medical Reports Q3 Revenue of $414,895 and Nine-Month Revenue of $1.29 Million
Vycor Medical reported revenue of $414,895 for the third quarter of 2026 and $1.29 million for the first nine months of the year. Gross profit was $353,017 for the quarter and $1.07 million year to date, while operating
EARNINGS | Nov 16, 2026, 12:03 PM UTC
L
Elauwit Connection Q3 Revenue Rises 17% to $5.6 Million; Recurring Units Expand
Elauwit Connection reported third-quarter 2026 revenue of $5.6 million, up 17% year over year, and a net loss of $2.6 million. Recurring service revenue increased 86% year over year to $1.5 million, while billed units gr
EARNINGS | Nov 16, 2026, 12:03 PM UTC
L
Instil Bio Reports Q3 2026 Net Loss of $4.2 Million and $67.1 Million in Cash and Investments
Instil Bio reported a third-quarter 2026 net loss of $4.2 million, or $0.62 per share, compared with a $13.6 million net loss a year earlier. The company ended September with $67.1 million in cash, restricted cash, marke
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
Broadridge and Coinbase Publish Onchain Shareholder Communications Standard
The companies published a jointly developed open technical standard for delivering shareholder communications onchain. Broadridge also launched a data oracle.
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
Faeth Therapeutics Signs Roche Collaboration on Breast Cancer Study
Faeth will sponsor and run a Phase 1b/2 study evaluating PIKTOR with Roche’s giredestrant in HR+/HER2- breast cancer.
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
Asian Stocks Close Mixed
Asian markets finished mostly lower on Monday, with the Hang Seng higher.
EQUITY | Nov 16, 2026, 12:03 PM UTC
L
Aramark Posts Higher Profit, Revenue on New Business, Improved Retention
By Connor HartAramark reported higher profit and revenue in the latest quarter, as the company won new business and retained its existing customers.The food-services and facilities-management company posted a profit of $
EARNINGS | Nov 16, 2026, 12:03 PM UTC
L
AsiaFIN Turns to Q3 Net Loss of US$57,734; Q3 Revenue Falls 26% to US$1.17 Million
AsiaFIN Turns to Q3 Net Loss of US$57,734; Q3 Revenue Falls 26% to US$1.17 Million AsiaFIN Holdi
EARNINGS | Nov 16, 2026, 12:03 PM UTC
L
Buffett Donates 9,225,000 Berkshire Hathaway Class B Shares
Warren E. Buffett donated 9,225,000 Class B shares, reducing his stake in Berkshire Hathaway.
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Aker BP completes LTIP share awards and issues new grants
Aker BP ASA finalised share awards under its 2023–2026 Long-Term Incentive Programme.
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Helus Pharma (HELP) Reports Positive Phase 3 MDD Trial Results
Helus Pharma reported HLP003 reduced MADRS scores versus placebo by 7.6 points at Week 6 and 7.0 points at Week 12 in the Phase 3 APPROACH trial; both differences were statistically significant (p<0.0001).Material Detail
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Matternet Appoints Ben Dobson as CFO
Ben Dobson joins from Joby Aviation, where he served as Head of Finance since 2021.
EQUITY | Nov 16, 2026, 12:02 PM UTC
M
Macerich Acquires San Jose’s Oakridge Mall for About $250 Million
EQUITY | Nov 16, 2026, 12:02 PM UTC
H
GXO Logistics, Inc. (GXO) Sets 2027 Outlook And 2030 Financial Targets
GXO disclosed initial full-year 2027 financial outlook and 2030 targets for organic revenue CAGR, adjusted EBITA margin and free cash flow conversion. The target values are not stated in the provided release text.Materia
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlook
RONAN, Mont., Nov. 16, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation NASDAQ:AIRJ (“AIRJ” or the “Company”) today reported financial and operating results for the third quarter ended September 30, 2026.“This
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Selkirk Copper Completes Phase 2 Drill Program Comprising 54,579 Metres in 223 Drill Holes and Reports Additional High-Grade Results from Fo
HighlightsVancouver, British Columbia and Pelly Crossing, Yukon--(. - November 16, 2026) - Selkirk Copper Mines Inc. TSXV:SCMI (FSE: IO20) (OTCQX: SKRKF) ("Selkirk Copper" or the "Company") is pleased to announce complet
COMMODITIES | Nov 16, 2026, 12:02 PM UTC
L
Rubicon Organics Inc. (ROMJ) Q3 Revenue Rose 17% to C$18.3M
Q3 revenue was C$18.3M, up 17% year over year, and Adjusted EBITDA was C$1.4M. Cascadia generated approximately C$2.3M in its first full quarter of contribution; management expects continued revenue growth through the re
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
AirJoule Technologies Corporation (AIRJ) Reports Q3 Results; BitSink Has $15M in Signed Orders
AirJoule Technologies reported Q3 2026 results and preliminary 2027 BitSink outlook. BitSink had $15M in signed purchase orders; no prior-period comparison was provided.Material DetailsContext by AI AnalystThe report ref
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Aben Gold Reports First Assay Results from the 2026 Drill Program
Vancouver, BC, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) (“Aben” or “the Company”) is pleased to report initial assay results from diamond drill hole JN26-003, the fir
COMMODITIES | Nov 16, 2026, 12:02 PM UTC
L
GT Biopharma, Inc. (GTBP) Reports $3.5M Q3 Net Loss
GT Biopharma reported Q3 2026 net loss of approximately $3.5M, versus net income of $8.3M in Q3 2025; the prior-period result included $11.4M of non-cash income from a fair-value change. Cash of approximately $10M is exp
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Di
HLP003 achieved statistically significant and clinically meaningful results in the primary and key secondary endpoints starting as early as Day 2 and maintained at all time points-7.6 point placebo-adjusted change from b
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
POET Technologies Names Giovanni Pacelli CFO
Giovanni Pacelli will succeed Thomas Mika as CFO of POET Technologies.
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Duke Robotics Corp. (DUKR) Q3 Revenue Rose 38% YoY; Cash Runway Expected Into 2028
Duke Robotics reported third-quarter revenue up 38% year over year. Cash and restricted cash were $6.5M at September 30, 2026, versus $750K at December 31, 2025; the company expects resources to support operations into 2
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
NextSource Materials Appoints Eugene Lee CFO Effective Dec. 1
Eugene Lee will succeed interim CFO Jaco Crouse, who has served in the role since March 2026.
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
AIRJOULE TECHNOLOGIES: AIRJ'S PRELIMINARY 2027 REVENUE OUTLOOK FOR BITSINK IS $15 MLN TO $20 MLN OF REVENUE IN 2027
AIRJOULE TECHNOLOGIES: AIRJ'S PRELIMINARY 2027 REVENUE OUTLOOK FOR BITSINK IS $15 MLN TO $20 MLN OF
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
Rubicon Organics Reports Q3 2026 Financial Results
VANCOUVER, British Columbia, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. TSXV:ROMJ OTCQX:ROMJF (“Rubicon Organics” or the “Company”), Canada’s leading licensed producer of premium cannabis products, announces
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
International Battery Metals Ltd. (IBAT) Posts $2.2M Q2 Net Income, Down 27% YoY
For the three months ended September 30, 2026, revenue was $0 versus $64K a year earlier and net income was $2.2M versus $3.0M. The company reported an operating loss of $2.9M, compared with $3.4M.Material DetailsContext
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Rep
Participants in high-dose cohorts achieved 80% mean reduction in non-sustained ventricular tachycardia and 44% mean reduction in premature ventricular contractions at latest assessmentLX2020 generally well tolerated acro
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
BRIEF-Prelude Therapeutics Q3 EPS USD -0.12
Nov 16 (Reuters) - Prelude Therapeutics Q3 net income USD -12.544 million.
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
BRIEF-Invivyd Q3 EPS USD -0.1
Nov 16 (Reuters) - Invivyd Q3 net income USD -33.468 million.
EARNINGS | Nov 16, 2026, 12:02 PM UTC
M
Scotia Metals Secures Option to Acquire Nordestina Lithium Project
Scotia Metals says it has secured an option to acquire 100% of the Nordestina Lithium Project in Brazil. The company also reports spodumene-bearing pegmatites mapped along a 3.3 km corridor.
EQUITY | Nov 16, 2026, 12:02 PM UTC
M
Uber and Zoox to Launch in Los Angeles by End of 2026
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
BRIEF-Prelude Therapeutics Q3 EPS USD -0.12
BRIEF-Prelude Therapeutics Q3 EPS USD -0.12 Nov 16 (Reuters) - Prelude Therapeutics Q3 net income US
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
Sasquatch Resources Completes Acquisition of Echo Property
Sasquatch Resources says it has closed its previously announced acquisition of the Echo Property, comprising eight mineral claims in British Columbia.
MNA | Nov 16, 2026, 12:02 PM UTC
L
Uber Partners With Zoox to Offer Robotaxi Rides in Las Vegas
Uber launched Zoox robotaxis on its platform in Las Vegas.
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
DALLAS, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) NASDAQ:TIL, a biotechnology company building a portfolio of asset-focused subsidiaries to develop novel therapies for unmet medical needs, today repor
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
BRIEF-Invivyd Q3 EPS USD -0.1
BRIEF-Invivyd Q3 EPS USD -0.1 Nov 16 (Reuters) - Invivyd Q3 net income USD -33.468 million. Q3 reven
EARNINGS | Nov 16, 2026, 12:02 PM UTC
L
GT Biopharma Reports Third Quarter 2026 Financial Results
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 remains ongoing, with an
EQUITY | Nov 16, 2026, 12:02 PM UTC
M
Falcon Energy Materials Closes 49% Weihai Stake Acquisition for $22M
Falcon paid $22 million in cash for a 49% non-operating equity interest in Weihai. Weihai is profitable and has a 25,000 tpa CSPG production circuit.
MNA | Nov 16, 2026, 12:02 PM UTC
L
Duke Robotics Reports Third Quarter 2026 Financial Results and Provides Business Update
Commercial Expansion of IC Drone Platform into Greece Through Strategic Collaboration with CRONOS; Potential Large-Scale Projects Already Identified with the Potential to Represent Tens of Millions of Euros in Aggregate
EQUITY | Nov 16, 2026, 12:02 PM UTC
L
Church & Dwight expects investment to add to cash earnings in 2027
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
TORONTO, ON / / November 16, 2026 / NextSource Materials Inc. TSX:NEXTOTC:NSRCF ("NextSource" or the "Company") announces the appointment of Eugene Lee as Chief Financial Officer (CFO) of the Company, effective December
EQUITY | Nov 16, 2026, 12:01 PM UTC
H
AIRJOULE TECHNOLOGIES: REAFFIRMED GUIDANCE FOR $27 MLN TO $28 MLN OF COMBINED AIRJ & AIRJOULE JOINT VENTURE CASH SPENDING IN 2026, EXCLUDING
AIRJOULE TECHNOLOGIES: REAFFIRMED GUIDANCE FOR $27 MLN TO $28 MLN OF COMBINED AIRJ & AIRJOULE JOINT
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 2025
LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 202
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Railtown AI Demonstrates Siri Experiences Powered by Swift ADK
Railtown AI says demonstrations show Siri connecting specialized AI agents, persistent knowledge and native Apple applications.
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Church & Dwight Has Option to Buy Remaining 55% After Two Years
MNA | Nov 16, 2026, 12:01 PM UTC
L
NABLUS SURGICAL CENTER Q3 OPERATING REVENUE JOD 2.1 MLN
NABLUS SURGICAL CENTER Q3 OPERATING REVENUE JOD 2.1 MLN
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Aben Gold Reports First Assay Results from the 2026 Drill Program
Vancouver, BC, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp.
COMMODITIES | Nov 16, 2026, 12:01 PM UTC
L
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
VANCOUVER, BC & HOUSTON, TX / / November 16, 2026 / International Battery Metals Ltd. ("IBAT" or the "Company") TSXV:IBATOTC:IBATF, an advanced technology provider of modular direct lithium extraction (DLE) systems, toda
EQUITY | Nov 16, 2026, 12:01 PM UTC
M
Uber and Zoox Announce Multi-Year MGM Resorts Partnership
Uber and Zoox announced a multi-year partnership with MGM Resorts in Las Vegas.
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Lexeo Therapeutics 3Q Loss/Shr 43c >LXEO
Lexeo Therapeutics 3Q Loss/Shr 43c >LXEO
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
KUALA LUMPUR, MY / / November 16, 2026 / AsiaFIN Holdings Corp. OTC:ASFH, a global financial ecosystem enabler, today announced its financial results for the third quarter of 2026 ended September 30, 2026, reporting stro
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
NABLUS SURGICAL CENTER Q3 NET PROFIT AFTER TAX JOD 111,808
NABLUS SURGICAL CENTER Q3 NET PROFIT AFTER TAX JOD 111,808
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Falcon Energy Materials Closes Acquisition of 49% Interest in Weihai
Falcon Energy Materials says it has closed its previously announced acquisition of a 49% strategic, non-operating equity interest in Weihai Hensen New…
MNA | Nov 16, 2026, 12:01 PM UTC
L
GXO LOGISTICS - PRELIM 2027 OUTLOOK: >5.5% ORGANIC REVENUE GROWTH, >7.1% ADJ EBITDA MARGIN, >4.5% ADJ EBITA MARGIN
GXO LOGISTICS - PRELIM 2027 OUTLOOK: >5.5% ORGANIC REVENUE GROWTH, >7.1% ADJ EBITDA MARGIN, >4.5% AD
EARNINGS | Nov 16, 2026, 12:01 PM UTC
M
Church & Dwight to Buy 45% of Bali Treatment for $225 Million
MNA | Nov 16, 2026, 12:01 PM UTC
L
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights
DECLARATION Phase 3 clinical trial data on VYD2311 (ibramvibart) to be available imminently, per the
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Uber launches Zoox robotaxis in Las Vegas
Uber launches Zoox fully autonomous robotaxis in Las Vegas.
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Eloxx Pharmaceuticals, Inc. (ELOX) Reports $5.5M Q3 Net Loss; Cash Runway Into 2028
Eloxx reported a Q3 2026 net loss of $5.5M, versus $0.4M in Q3 2025, and cash of $56.3M at September 30, versus $62.0M at June 30. The company said cash is expected to fund operations into 2028.Material DetailsContext by
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Enrollment of Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.44
BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.44 Nov 16 (Reuters) - Cypherpunk Technologies Inc Q3
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Rubicon Organics Q3 Revenue CAD 18.3 Million
BRIEF-Rubicon Organics Q3 Revenue CAD 18.3 Million Nov 16 (Reuters) - Rubicon Organics Q3 adjusted E
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
INVIVYD Q3 NET INCOME USD -33.468 MILLION
INVIVYD Q3 NET INCOME USD -33.468 MILLION
FX | Nov 16, 2026, 12:01 PM UTC
L
INVIVYD Q3 EPS USD -0.1
INVIVYD Q3 EPS USD -0.1
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Xtant Medical Q3 Revenue USD 24.3 Million
BRIEF-Xtant Medical Q3 Revenue USD 24.3 Million Nov 16 (Reuters) - Xtant Medical Q3 net income USD
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
INVIVYD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
INVIVYD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-POET Technologies Q3 EPS USD -0.04
BRIEF-POET Technologies Q3 EPS USD -0.04 Nov 16 (Reuters) - POET Technologies Q3 net income USD -7.6
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
PRELUDE THERAPEUTICS Q3 EPS USD -0.12
PRELUDE THERAPEUTICS Q3 EPS USD -0.12
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
INVIVYD Q3 REVENUE USD 15.449 MILLION
INVIVYD Q3 REVENUE USD 15.449 MILLION
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
PRELUDE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PRELUDE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Instil Bio Q3 Basic EPS USD -0.62
BRIEF-Instil Bio Q3 Basic EPS USD -0.62 Nov 16 (Reuters) - Instil Bio Q3 operating expenses USD 5.98
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
PRELUDE THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -14.265 MILLION
PRELUDE THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -14.265 MILLION
FX | Nov 16, 2026, 12:01 PM UTC
L
Lexeo Therapeutics 3Q Loss $38.3M >LXEO
Lexeo Therapeutics 3Q Loss $38.3M >LXEO
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Insight Enterprises Intends to Use Up to $100 Million for Stock Repurchases
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights DECLARATION Phas
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Enro
EQUITY | Nov 16, 2026, 12:01 PM UTC